Daniel Markwardt

971 total citations
8 papers, 121 citations indexed

About

Daniel Markwardt is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Daniel Markwardt has authored 8 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Daniel Markwardt's work include Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Daniel Markwardt is often cited by papers focused on Liver Disease and Transplantation (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Daniel Markwardt collaborates with scholars based in Germany, Denmark and United Kingdom. Daniel Markwardt's co-authors include Alexander L. Gerbes, Christian J. Steib, Vicente Arroyo, Daniel Teupser, Flemming Bendtsen, Mauro Bernardi, Elisabet García, Frederik Nevens, Andreas Benesic and Lesca M. Holdt and has published in prestigious journals such as Hepatology, European Journal of Clinical Investigation and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Daniel Markwardt

7 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Markwardt Germany	5	101	60	40	37	15	8	121
Octavi Bassegoda Spain	7	137 1.4×	112 1.9×	30 0.8×	62 1.7×	23 1.5×	18	171
Amoako Duah Ghana	9	113 1.1×	102 1.7×	13 0.3×	47 1.3×	7 0.5×	23	158
Zainib Shabir United Kingdom	5	72 0.7×	75 1.3×	11 0.3×	24 0.6×	22 1.5×	6	109
Danielle Adebayo United Kingdom	8	238 2.4×	196 3.3×	30 0.8×	110 3.0×	46 3.1×	14	284
Valeria Calvino Italy	7	208 2.1×	155 2.6×	57 1.4×	105 2.8×	31 2.1×	16	247
Tammo Lambert Tergast Germany	9	213 2.1×	189 3.1×	17 0.4×	84 2.3×	29 1.9×	31	240
Krish Menon United Kingdom	5	58 0.6×	42 0.7×	7 0.2×	49 1.3×	10 0.7×	9	108
Alessandra Galioto Italy	6	134 1.3×	107 1.8×	23 0.6×	60 1.6×	10 0.7×	7	160
David Toapanta Spain	6	65 0.6×	66 1.1×	5 0.1×	27 0.7×	30 2.0×	17	134
Elisabetta Pierucci Italy	8	70 0.7×	25 0.4×	11 0.3×	79 2.1×	5 0.3×	10	140

Countries citing papers authored by Daniel Markwardt

Since Specialization

Citations

This map shows the geographic impact of Daniel Markwardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Markwardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Markwardt more than expected).

Fields of papers citing papers by Daniel Markwardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Markwardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Markwardt. The network helps show where Daniel Markwardt may publish in the future.

Co-authorship network of co-authors of Daniel Markwardt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Markwardt. A scholar is included among the top collaborators of Daniel Markwardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Markwardt. Daniel Markwardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Philipp, Alexander, Daniel Markwardt, Kathrin Heinrich, et al.. (2025). Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report. Oncology Research and Treatment. 48(9). 548–554.

Heinrich, Kathrin, Laura Fischer, Enrico N. De Toni, et al.. (2023). Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy. JCO Precision Oncology. 7(7). e2200650–e2200650. 1 indexed citations

Erickson, Nicole, Arndt Stahler, Maximilian Muenchhoff, et al.. (2022). Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. Medical Oncology. 39(6). 104–104. 1 indexed citations

Roessler, Daniel, Osman Öcal, Alexander Philipp, et al.. (2022). Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study. Journal of Cancer Research and Clinical Oncology. 149(7). 3065–3073. 19 indexed citations

Gabriel, Maria M., G. Kircheis, Svenja Hardtke, et al.. (2020). Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. European Journal of Gastroenterology & Hepatology. 33(9). 1185–1193. 13 indexed citations

Wieser, Andreas, Hanwei Li, Jiang Zhang, et al.. (2019). Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis. Digestive and Liver Disease. 51(9). 1300–1307. 7 indexed citations

Li, Hanwei, Andreas Wieser, Jiang Zhang, et al.. (2019). Patients with cirrhosis and SBP: Increase in multidrug‐resistant organisms and complications. European Journal of Clinical Investigation. 50(2). e13198–e13198. 8 indexed citations

Markwardt, Daniel, Lesca M. Holdt, Christian J. Steib, et al.. (2017). Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. Hepatology. 66(4). 1232–1241. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact